Powered By
| The Lexiva brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Lexiva was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Lexiva is also referred to by its drug name, fosamprenavir.
Lexiva was an antiviral medication of the protease inhibitor (PI) class. Lexiva was believed to work by preventing HIV from replicating in cells.
How was it taken?
Prescribing information stated that Lexiva was taken once or twice daily. Lexiva came in tablet and oral suspension forms.
Side effects
The FDA-approved label for Lexiva listed common side effects including headache, nausea, diarrhea, vomiting, fatigue, and pain in the stomach or abdomen.
Rare but serious side effects listed for Lexiva included severe skin reactions.
For more details about this treatment, visit:
Become a member to get even more
Join
